title: CALR mutations screening should not be studied in splanchnic vein thrombosis.
authors: Haematology Department, Hospital Universitario 12 de Octubre, Departamento de Medicina Universidad Complutense de Madrid, Madrid, Spain.
authors: Nerea
authors: N
authors: Castro
authors: Haematology Department, Hospital Universitario 12 de Octubre, Departamento de Medicina Universidad Complutense de Madrid, Madrid, Spain.
authors: Inmaculada
authors: I
authors: Rapado
authors: Haematology Department, Hospital Universitario 12 de Octubre, Departamento de Medicina Universidad Complutense de Madrid, Madrid, Spain.
authors: Rosa
authors: R
authors: Ayala
authors: Haematology Department, Hospital Universitario 12 de Octubre, Departamento de Medicina Universidad Complutense de Madrid, Madrid, Spain. jmarti01@ucm.es, jmartinezlo@yahoo.es.
authors: Joaquin
authors: J
authors: Martinez-Lopez
mesh_terms: D037282:Calreticulin / Q000235:genetics*; D005260:Female; D006801:Humans; D008297:Male; D009154:Mutation; D013152:Splanchnic Circulation; D020246:Venous Thrombosis / Q000235:genetics*
chemical_list: D037282:Calreticulin
keywords: CALR mutations; myeloproliferative neoplasms; splanchnic vein thrombosis